GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » General Biologicals Corp (ROCO:4117) » Definitions » YoY Rev. per Sh. Growth

General Biologicals (ROCO:4117) YoY Rev. per Sh. Growth : 7.45% (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is General Biologicals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. General Biologicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was 7.45%.

General Biologicals's Revenue per Share for the six months ended in Dec. 2024 was NT$2.35.


General Biologicals YoY Rev. per Sh. Growth Historical Data

The historical data trend for General Biologicals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

General Biologicals YoY Rev. per Sh. Growth Chart

General Biologicals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.43 2.20 -32.76 -28.59 -4.79

General Biologicals Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.17 -40.79 -9.14 -16.78 7.45

General Biologicals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

General Biologicals's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2024 )
=(Revenue per Share (A: Dec. 2024 )-Revenue per Share (A: Dec. 2023 ))/ | Revenue per Share (A: Dec. 2023 ) |
=(4.21-4.422)/ | 4.422 |
=-4.79 %

General Biologicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=(Revenue per Share (Q: Dec. 2024 )-Revenue per Share (Q: Dec. 2023 )) / | Revenue per Share (Q: Dec. 2023 )) |
=(2.35-2.187)/ | 2.187 |
=7.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


General Biologicals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of General Biologicals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


General Biologicals Business Description

Traded in Other Exchanges
N/A
Address
No-6, Innovation First Road, Hsinchu Science Park, Hsinchu, TWN, 300092
General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.

General Biologicals Headlines

No Headlines